Skip to main content
Equibles

Invesco Ltd.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 914208 Atlanta, GA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$867,944
-$1,430,740 QoQ
Shares Held
59,530
-67.3% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ENTA ranks #157 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $867,944 59,530
2026-03-31 $2,298,684 182,002
2025-12-31 $4,002,599 253,811
2025-09-30 $714,584 59,698
2025-06-30 $475,402 62,884
2025-03-31 $332,727 60,277
2024-12-31 $268,030 46,614
2024-09-30 $449,913 43,428
2024-06-30 $562,429 43,364
2024-03-31 $759,492 43,499
2023-12-31 $190,382 20,232
2023-09-30 $207,381 18,566
2023-06-30 $1,800,230 84,123
2023-03-31 $12,203,576 301,770
2022-12-31 $4,958,983 106,599
2022-09-30 $18,474,899 356,177
2022-06-30 $23,612,781 499,530
2022-03-31 $24,344,057 342,007
2021-12-31 $21,674,533 289,844
2021-09-30 $6,031,403 106,168
2021-06-30 $12,374,027 281,164
2021-03-31 $16,056,420 325,556
2020-12-31 $23,711,181 563,211
2020-09-30 $24,502,142 535,215
2020-06-30 $5,819,488 115,903
2020-03-31 $12,155,171 236,344